An open label,fixed sequence study to evaluate safety and pharmacokinetic drug–drug interactions of LCZ696 coadministered with Simvastatin in healthy subjects

Trial Profile

An open label,fixed sequence study to evaluate safety and pharmacokinetic drug–drug interactions of LCZ696 coadministered with Simvastatin in healthy subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 26 Apr 2017

At a glance

  • Drugs Sacubitril/valsartan (Primary) ; Simvastatin
  • Indications Heart failure
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 26 Apr 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top